Inhibition of SIRT1 combined with gemcitabine therapy for pancreatic carcinoma
Dao-Jun Gong,1 Jia-Min Zhang,1 Min Yu,1 Bo Zhuang,1 Qing-Qu Guo21Department of Hepatobiliary-Pancreatic Surgery, Jinhua Hospital of Zhejiang University, Jinhua, People's Republic of China; 2Department of Surgery, Second Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou...
Guardado en:
Autores principales: | Gong DJ, Zhang JM, Yu M, Zhuang B, Guo QQ |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5f425470771c4c219e847a9fc2307b54 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Application of 18F-FDG PET/CT combined with carbohydrate antigen 19-9 for differentiating pancreatic carcinoma from chronic mass-forming pancreatitis in Chinese elderly
por: Gu X, et al.
Publicado: (2016) -
Circ_0092367 Inhibits EMT and Gemcitabine Resistance in Pancreatic Cancer via Regulating the miR-1206/ESRP1 Axis
por: Shuo Yu, et al.
Publicado: (2021) -
Resveratrol in prevention and treatment of common clinical conditions of aging
por: M Andrea Markus, et al.
Publicado: (2008) -
Elderly persons with acute pancreatitis – specifics of the clinical course of the disease
por: Koziel D, et al.
Publicado: (2018) -
Neuroprotective role of retinal SIRT3 against acute photo-stress
por: Norimitsu Ban, et al.
Publicado: (2017)